SEC Form 4 · accession 0001140361-18-032158

Loxo Oncology, Inc. · LOXO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Joshua H. Bilenker

Officer — President & CEO · Director

Period of report

Jul 9, 2018

Accepted (ET)

Jul 11, 2018 · 5:01 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001581720

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 9, 2018	M	7,500	$1.184	A	142,907	D
Common Stock^F2,F3	Jul 9, 2018	S	900	$184.8698	D	142,007	D
Common Stock^F2,F4	Jul 9, 2018	S	1,500	$186.3849	D	140,507	D
Common Stock^F2,F5	Jul 9, 2018	S	3,698	$187.3871	D	136,809	D
Common Stock^F2,F6	Jul 9, 2018	S	802	$188.2849	D	136,007	D
Common Stock^F2,F7	Jul 9, 2018	S	300	$189.43	D	135,707	D
Common Stock^F2,F8	Jul 9, 2018	S	300	$191.6333	D	135,407	D
Common Stock	Jul 10, 2018	M	7,500	$1.184	A	142,907	D
Common Stock^F2,F9	Jul 10, 2018	S	2,200	$178.1923	D	140,707	D
Common Stock^F2,F10	Jul 10, 2018	S	2,200	$179.0809	D	138,507	D
Common Stock^F2,F11	Jul 10, 2018	S	1,000	$180.081	D	137,507	D
Common Stock^F2,F12	Jul 10, 2018	S	1,300	$181.2077	D	136,207	D
Common Stock^F2,F13	Jul 10, 2018	S	800	$182.8388	D	135,407	D
Common Stock	holding	—	—		—	30,000	I	By Joshua H Bilenker, ttee Joshua H Bilenker 2018 GRAT, dated 06/20/2018

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F14	$1.184	Jul 9, 2018	M	7,500	D	—	Nov 14, 2023	Common Stock	7,500	101,432	D
Employee Stock Option (right to buy)^F14	$1.184	Jul 10, 2018	M	7,500	D	—	Nov 14, 2023	Common Stock	7,500	93,932	D

Explanation of responses

F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F10Represents the weighted average sales price per share. The shares sold at prices ranging from $178.60 to $179.49 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F11Represents the weighted average sales price per share. The shares sold at prices ranging from $179.60 to $180.54 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F12Represents the weighted average sales price per share. The shares sold at prices ranging from $180.93 to $181.92 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F13Represents the weighted average sales price per share. The shares sold at prices ranging from $182.50 to $183.19 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F14The options have fully vested and are immediately exercisable.
F2Represents the aggregate of sales effected on the same day at different prices.
F3Represents the weighted average sales price per share. The shares sold at prices ranging from $184.72 to $185.57 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4Represents the weighted average sales price per share. The shares sold at prices ranging from $185.73 to $186.70 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5Represents the weighted average sales price per share. The shares sold at prices ranging from $186.94 to $187.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F6Represents the weighted average sales price per share. The shares sold at prices ranging from $188.04 to $188.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F7Represents the weighted average sales price per share. The shares sold at prices ranging from $189.12 to $190.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F8Represents the weighted average sales price per share. The shares sold at prices ranging from $191.63 to $191.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F9Represents the weighted average sales price per share. The shares sold at prices ranging from $177.57 to $178.52 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.